awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42183463-92E18C78-7367-41E4-AC31-84E3CE627F5E
Q42183463-92E18C78-7367-41E4-AC31-84E3CE627F5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42183463-92E18C78-7367-41E4-AC31-84E3CE627F5E
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.
P2860
Q42183463-92E18C78-7367-41E4-AC31-84E3CE627F5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42183463-92E18C78-7367-41E4-AC31-84E3CE627F5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b8a33ef610ba16fd40ec4df77a8c0c8b981819b
P2860
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.